FDA Inspection
VitalantVitalant – FDA Inspection, May 15, 2019
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on May 15, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 46df109c-0c64-457a-897e-19c0c96ee5b8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1090371
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 630.10(c)Donor Eligibility on day of donation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 15, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 6, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 15, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 13, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1242507 - 2024-06-27
- FDA Inspection 1021901 - 2017-08-15
- FDA Inspection 918326 - 2015-03-06
- FDA Inspection 844627 - 2013-08-15
- FDA Inspection 749564 - 2011-10-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.